ST-001 nanoFenretinide logo

Phase 1 Clinical Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

 

ClinicalTrials.gov Identifier: NCT04234048

Follow Us

LinkedIn
Facebook
YouTube
Twitter - #SciTechUSA - SciTech Development
Instagram
google icon